Pushing the forefront of
therapeutic antibody discovery
Discover the advantage of choosing OmniAb for antibody discovery
OmniAb partners enjoy full access to the most comprehensive and cutting-edge suite of clinically proven antibody discovery technologies available.
a unique innovation in
transgenic animal platforms
Because chickens are evolutionarily more distant than rodents are to humans, they produce stronger and more diverse antibody responses to many target antigens, especially those that are conserved among mammals. This makes chickens ideal immunization hosts for therapeutic antibody discovery.
releases about OmniAb technology.
Publications & Presentations
Search and browse recent presentations and peer-reviewed publications about OmniAb technology
Become an OmniAb partner
See how more than 65 biopharmaceutical companies and research institutions worldwide are using OmniAb technology and capabilities to advance clinical drug development.
Get in Touch
Learn about our antibody discovery services
and find out which could work best for you.